Literature DB >> 16600735

Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis.

Vincenzo Ficarra1, Filiberto Zattoni, Walter Artibani, Andrea Fandella, Guido Martignoni, Giacomo Novara, Tommaso Prayer Galetti, Tiziano Zambolin, Michael W Kattan.   

Abstract

PURPOSE: In penile cancer the therapeutic benefits of early inguinal lymphadenectomy must be counterbalanced by the high rates of morbidity, postoperative complications and mortality. A relevant aim is optimizing the selection of the patients who could really have the highest survival advantage from inguinal lymphadenectomy, limiting the cases in which this surgery might be considered over treatment with a risk of severe complications. We generated a nomogram estimating the risk of pathological inguinal lymph node involvement according to clinical lymph node stage and pathological findings of the primary tumor.
MATERIALS AND METHODS: We retrospectively collected the clinical and pathological data of 175 patients who had undergone surgical therapy for squamous cell carcinoma of the penis from 1980 to 2002 at 11 urological centers in northeastern Italy. A logistic regression model was used to construct the nomogram.
RESULTS: The presence of palpable groin lymph nodes and the histological findings of vascular and/or lymphatic embolization were important predictors of metastatic inguinal lymph node involvement. The nomogram predicting the risk of metastatic lymph node involvement showed a good concordance index (0.876) and good calibration.
CONCLUSIONS: The clinical stage of groin lymph nodes and pathological findings of penectomy specimens allowed us to generate a nomogram to predict the probability of metastatic lymph node involvement in patients with squamous cell carcinoma of the penis. The statistical model showed an excellent ability to identify the patients with lymph node metastases and good calibration.

Entities:  

Mesh:

Year:  2006        PMID: 16600735     DOI: 10.1016/S0022-5347(05)01003-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

1.  Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort.

Authors:  X Melody Qu; D Robert Siemens; Alexander V Louie; Darwin Yip; Aamer Mahmud
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

Review 2.  [The significance of lymphadenectomy in the management of penile cancer].

Authors:  M Angerer-Shpilenya; G Jakse
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

Review 3.  Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer.

Authors:  Ben Hughes; Joost Leijte; Majid Shabbir; Nick Watkin; Simon Horenblas
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

4.  Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.

Authors:  Daniele Minardi; Guendalina Lucarini; Alessandra Filosa; Antonio Zizzi; Oriana Simonetti; Anna Maria Offidani; Gianluca d'Anzeo; Roberto Di Primio; Rodolfo Montironi; Giovanni Muzzonigro
Journal:  Cell Oncol (Dordr)       Date:  2012-09-13       Impact factor: 6.730

5.  Buried penis: An unrecognized risk factor in the development of invasive penile cancer.

Authors:  Alym Abdulla; Dean Daya; Jehonathan Pinthus; Timothy Davies
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

6.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 7.  How accurate are present risk group assignment tools in penile cancer?

Authors:  Vincenzo Ficarra; G Novara; R Boscolo-Berto; W Artibani; M W Kattan
Journal:  World J Urol       Date:  2008-06-17       Impact factor: 4.226

Review 8.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

9.  DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.

Authors:  Oliver J Kayes; Marco Loddo; Nimish Patel; Pranav Patel; Suks Minhas; Gareth Ambler; Alex Freeman; Alex Wollenschlaeger; David J Ralph; Kai Stoeber; Gareth H Williams
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

Review 10.  Multimodality therapy in penile cancer: when and which treatments?

Authors:  Lance C Pagliaro; Juanita Crook
Journal:  World J Urol       Date:  2008-08-06       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.